Aim: Endometrial cancer is the most common cancer of the female reproductive tract in the developed countries. There are many risk factors defined for the development of endometrial cancer, including obesity. We aimed to evaluate the significance of adiposity on the survival outcomes of the patients with endometrial cancer.

Methods: The patients diagnosed with endometrial cancer and underwent surgery between April 2009 and October 2017 were retrospectively reviewed. The visceral adipose tissue and subcutaneous adipose tissue volumes were measured at the level of umbilicus on single-slice magnetic resonance imaging. Visceral adiposity index was calculated. Patients were compared regarding their clinical, demographical, pathologic and survival characteristics. Patients divided into low visceral adiposity (≤0.265, group 1) and high visceral adiposity (>0.265, group 2).

Results: A total of 186 patients were included in this retrospective study. There was no significant difference in terms of the demographical, clinical and tumor characteristics of the patients, except age, menopausal status, subcutaneous adipose tissue and visceral adipose tissue. Although no significant difference in progression-free survival and disease-specific survival was noted between groups (P = 0.181), more patients in group 2 died because of endometrial cancer as statistically significant (P = 0.024). Disease-specific survival showed a significant difference between groups according to the log-rank test.

Conclusion: Visceral adiposity tissue is a significant and reliable prognostic indicator for endometrial cancer prognosis. Women diagnosed with endometrial cancer should be informed about the deleterious effects of visceral adiposity on disease-specific survival.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jog.14560DOI Listing

Publication Analysis

Top Keywords

visceral adiposity
24
endometrial cancer
24
adipose tissue
16
disease-specific survival
12
visceral
8
adiposity survival
8
survival outcomes
8
patients
8
outcomes patients
8
endometrial
8

Similar Publications

Fat distribution changes with advancing menopause, which predisposes to metabolic inflammation. However, it remains unclear, how health behaviours, including sleeping, eating and physical activity, or their combinations contribute to metabolic inflammation caused by visceral adipose tissue (VAT). The aim of the present study was to examine whether health behaviours are associated with metabolic inflammation and whether VAT mediates these associations in menopausal women.

View Article and Find Full Text PDF

Background: In people with HIV (PWH) who are virally suppressed (VS) on antiretroviral therapy (ART), abdominal obesity (AO) is linked to neurocognitive impairment (NCI), potentially due to visceral adiposity, inflammation, and reduced insulin-like growth factor 1 (IGF-1). Tesamorelin, a growth hormone-releasing hormone, reduces AO and increases IGF-1, suggesting it might mitigate NCI in VS PWH.

Methods: This 6-month, Phase II randomized, open-label clinical trial compared Tesamorelin versus standard-of-care (SOC) for NCI in abdominally obese PWH.

View Article and Find Full Text PDF

Baseline and cumulative Chinese visceral adiposity index and diabetic kidney disease: A prospective cohort study.

Diabetes Obes Metab

January 2025

Key Laboratory of Environmental Stress and Chronic Disease Control & Prevention, Ministry of Education, Department of Biostatistics and Epidemiology, School of Public Health, China Medical University, Shenyang, China.

Background: Diabetic kidney disease (DKD) makes up nearly half of all chronic kidney disease cases and is a major cause of mortality for people with diabetes. However, the study of the association of longitudinal Chinese visceral adiposity index (CVAI) with DKD is still missing.

Methods: This prospective cohort study included 7874 diabetes patients from the Kailuan study.

View Article and Find Full Text PDF

Chinese Visceral Adiposity Index Trajectory and Stroke in Prediabetes and Diabetes: A Prospective Cohort Study.

Diabetes Metab Res Rev

January 2025

Key Laboratory of Environmental Stress and Chronic Disease Control & Prevention, Department of Biostatistics and Epidemiology, Ministry of Education, School of Public Health, China Medical University, Shenyang, China.

Aims: Stroke is a common diabetic complication, by which the Chinese visceral adiposity index (CVAI) is confirmed as a better predictor of visceral fat. However, the relationship between CVAI change and the stroke risk among patients with diabetes and prediabetes remains unclear. Therefore, we aimed to examine the association of CVAI trajectory with the risk of stroke.

View Article and Find Full Text PDF

Independent effect of body fat content on inflammatory biomarkers in children and adolescents: The GENOBOX study.

Nutr Metab Cardiovasc Dis

November 2024

Growth, Exercise, Nutrition and Development (GENUD) Research Group, Department of Physiatry and Nursing, University of Zaragoza, 50009, Zaragoza, Spain; Pediatric Endocrinology Unit, Lozano Blesa Clinic Hospital, Faculty of Medicine, University of Zaragoza, 50009, Zaragoza, Spain; Aragon Agrofood Institute (IA2), Health Research Institute (IIS Aragón), University of Zaragoza, 50009, Zaragoza, Spain; Obesity and Nutrition Physiopathology Center (CIBERobn), Carlos III Health Institute, 28029, Madrid, Spain. Electronic address:

Background And Aims: To assess the relationship between body composition indicators and inflammatory biomarkers in children and adolescents of the GENOBOX study.

Methods And Results: Anthropometry data from 264 subjects from the subsample of Zaragoza (Spain) included: weight, height, waist circumference, body mass index and triponderal index. Body composition was determined by Dual-energy X-ray Absorptiometry (DXA), obtaining visceral adipose tissue, fat mass index and lean mass index.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!